TEVA250110P24000
- 0.00
- 0.000.00%
Teva Pharmaceutical Industries Newsroom
Sector Update: Health Care Stocks Advance Late Afternoon
Catalyst Pharmaceuticals Jumps 14% on Firdapse Settlement With Teva
Catalyst Pharmaceuticals Announces Settlement Of FIRDAPSE Patent Litigation With Teva Pharmaceuticals; Teva Will Not Market Its Generic Version Of FIRDAPSE In The U.S. Any Earlier Than February 25, 2035, If Approved By The FDA
Express News | Catalyst Pharmaceuticals Inc - Penging Firdapse Patent Litigation Against Hetero and Lupin Ongoing
Express News | Catalyst Pharmaceuticals Announces Settlement of Firdapse® (Amifampridine) Patent Litigation With Teva Pharmaceuticals
Express News | Teva Pharmaceuticals USA's Ezetimibe And Simvastatin, Tablet, 10 Mg; 10 Mg, 10 Mg; 20 Mg, 10 Mg; 20 Mg Discontinued
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Express News | Teva : BofA Global Research Raises Price Objective to $26 From $25
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
Novo Nordisk Seeks to Block Compounded Victoza
Insider Trades: Walmart, Teva Among Notable Names This Week
Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath
Teva Pharmaceutical Industries(TEVA.US) Director Sells US$6.29 Million in Common Stock
Teva Pharmaceutical on Track for Highest Close Since November 2018 -- Data Talk
TEVA Stock Soars to 52-week High, Reaches $22.52
Tesla, Avinger, Jet.Ai, Teva, And Netflix: Why These 5 Stocks Are On Investors' Radars Ahead Of Christmas
Teva Pharmaceutical Shares Surged for Seven Straight Sessions
FDA Approves First Generic of Novo Nordisk's Victoza
Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More